Mark Feider, National Director, Enterprise Sector at Genetec
False alarms in the healthcare setting directly impact the efficiency of security resources and the patient and staff experience. A recent study published in Science Direct noted…
Continue Reading
What You Should Know:
– Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
– Amgen will use the Veeva Clinical Platform to find and implement…
Continue Reading
Emphysema progression in chronic obstructive pulmonary disease (COPD) presents a notable challenge due to its significant variability among individuals and the current lack of reliable prognostic markers. Given the limited therapeutic options available for…
Continue Reading
What You Should Know:
– mPulse, a provider of Health Experience and Insights (HXI) technology, has acquired Clarity Software Solutions, a leader in health communications technology. Financial details of the acquisition were not disclsoed.
– The…
Continue Reading
Background: The association between physical activity behavior and cardiometabolic risk factors in longitudinal cohort studies has depended largely on questionnaire-based reporting. However, more studies are turning to mHealth device solutions, where physical activity (PA)…
Continue Reading
Professor Kamila Hawthorne, chair of the Royal College of GPs (Credit: Grainge Photography)
A study has suggested that AI should be used to support the delivery of primary care, after chatbots outperformed GPs based…
Continue Reading
Identification of cohorts at higher risk of cancer can enable earlier diagnosis of the disease, which significantly improves patient outcomes. In this study, we select nine cancer sites with high incidence of late-stage diagnosis…
Continue Reading
Timely care in a specialised neuro-intensive therapy unit (ITU) reduces mortality and hospital stays. Planned admissions to ITU following surgery are safer than unplanned ones. However, post-operative care decisions remain subjective. This study used…
Continue Reading
What You Should Know:
– Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight…
Continue Reading
What You Should Know:
– New data from Nomi Health reveals a counterintuitive trend dubbed the “MSK Paradox”: white-collar employees report significantly higher rates of musculoskeletal (MSK) disorders than their blue-collar counterparts.
– A national analysis…
Continue Reading
